Hexarelin
Also known as: Examorelin
Hexarelin (His-D-2MeTrp-Ala-Trp-D-Phe-Lys-NH2) is a synthetic hexapeptide growth hormone secretagogue developed by Mediolanum (Italy) in the 1990s. It is a potent ghrelin-receptor (GHSR-1a) agonist that also binds the CD36 scavenger receptor, giving it a cardioprotective signal distinct from other GHRPs. It is not FDA-approved for any indication and remains a research-only compound; its clinical development for GH deficiency and cardiac indications did not reach approval. A defining feature versus other GHRPs is rapid, pronounced tachyphylaxis with chronic daily dosing.
0 listings, ranked by trust score
Each row is a (vendor, peptide) pair. Click through for the listing detail, the vendor's full trust profile, and any COAs they've published.
No vendors carrying this peptide are indexed yet.
COAs for Hexarelin
5 third-party tests across 3 vendors. Each card links to the full report.
For
Hexarelin
by MedGe Peptides· batch HEX5LT12
For
Hexarelin
by MedGe Peptides· batch HEXSLT12
For
Hexarelin
by Skye Peptides· batch HEX25-5-001
For
Hexarelin
by Peptide Tech· batch 102-HN
Purity not on file
For
Hexarelin
by Skye Peptides· batch HEX25-5-001